What is POC Pharma?
Founded in 2019 and headquartered in Hong Kong, POC Pharma operates as a specialized SaaS provider dedicated to the pharmacy channel. The company addresses critical inefficiencies in the pharmaceutical supply chain by offering a suite of tools designed for customized customer engagement, data-driven treatment recommendations, and comprehensive multichannel commercialization. By bridging the gap between pharmaceutical manufacturers and retail pharmacy stakeholders, POC Pharma enables more precise market execution and improved patient outcomes. Its platform serves as a vital infrastructure layer for stakeholders looking to modernize their commercial operations in an increasingly digital-first healthcare environment.
How much funding has POC Pharma raised?
POC Pharma has raised a total of $4.5M across 1 funding round:
Angel/Seed
$4.5M
Angel/Seed (2021): $4.5M with participation from FJ Labs, Picus Capital, Goat Capital, 500 Global, and FEBE Ventures
Key Investors in POC Pharma
FJ Labs
FJ Labs is a venture firm specializing in angel investing at scale, with a primary focus on marketplaces and network effect businesses.
500 Global
500 Global is a prominent venture capital firm that invests in early-stage companies across the globe, providing extensive support to founders.
FEBE Ventures
FEBE Ventures is a seed-focused firm founded by experienced entrepreneurs, providing both capital and operational insights to startups in health tech and fintech.
What's next for POC Pharma?
Looking ahead, the capital infusion will likely be directed toward enhancing the platform's analytical capabilities and scaling its reach across key international markets. As the company matures, the focus will shift toward deepening its integration within existing pharmacy workflows and refining its recommendation engines to drive higher conversion rates for its enterprise clients. The backing from prominent venture firms suggests a clear path toward sustained growth and potential market leadership in the pharmacy-tech sector. Future strategic initiatives will likely prioritize the acquisition of talent and the expansion of its commercialization suite to meet the evolving demands of global pharmaceutical stakeholders.
See full POC Pharma company page
